Stay updated with breaking news from Beckley Psytech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The truth is always stranger than fiction, and once that's the case for this past week.
A psychedelic toad compound is being used as a potential treatment for alcoholism.
London researchers to assess possible therapeutic benefits of new synthetic drug made from mebufotenin
Open-label study will investigate the safety, efficacy and pharmacokinetics of BPL-003 in patients diagnosed with alcohol use disorder (AUD). BPL-003 is Beckley Psytech's patent-protected
Private psychedelics companies have raised hundreds of millions of dollars. Here are the biggest venture investors backing their efforts.